| Somatic mutations of calreticulin in myeloproliferative neoplasms T Klampfl, H Gisslinger, AS Harutyunyan, H Nivarthi, E Rumi, JD Milosevic, ... New England Journal of Medicine 369 (25), 2379-2390, 2013 | 2202 | 2013 |
| LZTR1 is a regulator of RAS ubiquitination and signaling JW Bigenzahn, GM Collu, F Kartnig, M Pieraks, GI Vladimer, LX Heinz, ... Science 362 (6419), 1171-1177, 2018 | 132 | 2018 |
| A reversible gene trap collection empowers haploid genetics in human cells T Bürckstümmer, C Banning, P Hainzl, R Schobesberger, C Kerzendorfer, ... Nature methods 10 (10), 965-971, 2013 | 108 | 2013 |
| Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells DA Lichtenstein, F Schischlik, L Shao, SM Steinberg, B Yates, HW Wang, ... Blood 138 (24), 2469-2484, 2021 | 59 | 2021 |
| MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation S Sdelci, AF Rendeiro, P Rathert, W You, JMG Lin, A Ringler, G Hofstätter, ... Nature genetics 51 (6), 990-998, 2019 | 56 | 2019 |
| Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms F Schischlik, R Jäger, F Rosebrock, E Hug, M Schuster, R Holly, E Fuchs, ... Blood, The Journal of the American Society of Hematology 134 (2), 199-210, 2019 | 55 | 2019 |
| Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia K Kapralova, M Horvathova, C Pecquet, J Fialova Kucerova, ... Blood, The Journal of the American Society of Hematology 128 (10), 1418-1423, 2016 | 44 | 2016 |
| Mutations in myeloproliferative neoplasms–their significance and clinical use F Schischlik, R Kralovics Expert Review of Hematology 10 (11), 961-973, 2017 | 29 | 2017 |
| Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemia M Moder, G Velimezi, M Owusu, A Mazouzi, M Wiedner, ... Nature communications 8 (1), 1238, 2017 | 27 | 2017 |
| Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking A Fauster, M Rebsamen, KL Willmann, A César-Razquin, E Girardi, ... Cell Death & Differentiation 26 (6), 1138-1155, 2019 | 26 | 2019 |
| Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti–PD-1 Therapy K Wang, S Patkar, JS Lee, EM Gertz, W Robinson, F Schischlik, ... Cancer discovery 12 (4), 1088-1105, 2022 | 16 | 2022 |
| Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera R Jäger, H Gisslinger, E Fuchs, E Bogner, JD Milosevic Feenstra, ... Blood 137 (3), 387-391, 2021 | 13 | 2021 |
| The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective S Ahmadi, P Sukprasert, R Vegesna, S Sinha, F Schischlik, N Artzi, ... Nature communications 13 (1), 1613, 2022 | 6 | 2022 |
| PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms JD Milosevic Feenstra, R Jäger, F Schischlik, D Ivanov, G Eisenwort, ... American Journal of Hematology 97 (4), 390-400, 2022 | 5 | 2022 |
| scRNA-seq analysis of colon and esophageal tumors uncovers abundant microbial reads in myeloid cells undergoing proinflammatory transcriptional alterations W Robinson, JK Stone, F Schischlik, B Gasmi, MC Kelly, C Seibert, ... bioRxiv, 2020.05. 14.096230, 2020 | 5* | 2020 |
| Synthetic lethality-based prediction of anti-SARS-CoV-2 targets LR Pal, K Cheng, NU Nair, L Martin-Sancho, S Sinha, Y Pu, L Riva, X Yin, ... Iscience 25 (5), 104311, 2022 | 4 | 2022 |
| Myelomonocytic skewing in vitro discriminates subgroups of patients with myelofibrosis with a different phenotype, a different mutational profile and different prognosis K Geissler, B Gisslinger, E Jäger, R Jäger, AI Schiefer, E Bogner, E Fuchs, ... Cancers 12 (8), 2291, 2020 | 3 | 2020 |
| Frequent mutations in the calreticulin gene CALR in myeloproliferative neoplasms K Thorsten, H Gisslinger, AS Harutyunyan, H Nivarthi, E Rumi, ... Blood 122 (21), LBA-1, 2013 | 3 | 2013 |
| Deconvolving clinically relevant cellular immune crosstalk from bulk gene expression using CODEFACS and LIRICS K Wang, S Patkar, JS Lee, EM Gertz, W Robinson, F Schischlik, ... bioRxiv, 2021.01. 20.427515, 2021 | 2 | 2021 |
| Overexpression of PD-L1 correlates with JAK2-V617F mutational burden and is associated with chromosome 9p uniparental disomy in MPN JDM Feenstra, F Schischlik, R Jäger, D Ivanov, G Eisenwort, A Keller, ... Blood 136, 24, 2020 | 2 | 2020 |
